James M Daly has sold stock and made no open-market buys since Sep 2019

James M. (Jim) Daly is a biopharmaceutical executive and independent director with more than 30 years of experience leading U.S. and global pharmaceutical businesses.( He serves on the Board of Directors of Madrigal Pharmaceuticals, Inc. as a director, where his role includes oversight and strategic guidance informed by extensive commercial leadership experience.( Daly has also served as a director at Acadia Pharmaceuticals, argenx SE, Bellicum Pharmaceuticals, Halozyme Therapeutics, Chimerix, and other life sciences companies, reflecting a broad governance portfolio in the sector.(

Before his current board roles, Daly was Executive Vice President and Chief Commercial Officer at Incyte Corporation, where he led the development of the company’s global commercial capabilities.( He previously spent about 10 years at Amgen, ultimately serving as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development.( Earlier in his career, he spent more than 16 years at Glaxo Wellcome/GlaxoSmithKline, rising to Senior Vice President and General Manager of major business units.( Daly holds a B.S. in Pharmacy and an M.B.A. from the University at Buffalo, The State University of New York.(

Written by Perplexity from public sources.